Skip to Content

ABG 30 (Morphine Sulfate Extended-Release 30 mg)

Pill with imprint ABG 30 is Purple, Round and has been identified as Morphine Sulfate Extended-Release 30 mg. It is supplied by Watson Pharmaceuticals.

Morphine is used in the treatment of chronic pain; neonatal abstinence syndrome; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 30 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for ABG 30

Morphine sulfate extended-release 30 mg ABG 30
Morphine sulfate extended-release 30 mg ABG 30
Morphine sulfate extended-release 30 mg ABG 30

Morphine Sulfate Extended-Release

Imprint
ABG 30
Strength
30 mg
Color
Purple
Shape
Round
Availability
Prescription only
Drug Class
Narcotic analgesics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Watson Pharmaceuticals
National Drug Code (NDC)
00591-3512

Get help with Imprint Code FAQs.

Related Images for "ABG 30"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.